欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-Fibronectin EIIIB mAbs

简要描述:

This antibody is specific for the FN-EIIIB splice variant expressed in the ECM of tumors, metastases, and other diseases characterized by ECM deposition.

产品参数:

Cat. No.:MABL-1600

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:immunoblot, in vivo, ELISA, IF, IHC

详细介绍

Key features and   details


Cat. No.

MABL-1600

Name

Anti-Fibronectin EIIIB mAbs

Clone No.

AFD- NJB2

From

Recombinant Antibody

Isotype

Engineer antibody

Application

immunoblot, in vivo, ELISA, IF, IHC

Species Reactivity

Human, Mouse

Basic Information


Specificity

This antibody is specific for the FN-EIIIB   splice variant expressed in the ECM of tumors, metastases, and other diseases   characterized by ECM deposition.

Alternative Name

FN-EIIIB; EDB domain of fibronectin

UniProt


Immunogen

The original antibody was isolated from an   alpaca-derived phage display library, by panning against the EIIIB domain of  fibronectin.

Application Notes

This nanobody was shown to detect primary tumors and metastatic sites in vivo by specifically binding to the ECM with excellent specificity in multiple models of breast cancer, including human and mouse triple-negative breast cancer, and in melanoma, as measured by   PET/CT imaging with 64 Cu-NJB2. This nanobody recognized EIIIB-His by ELISA and in FN-containing EIIIB immunohistochemistry (IHC). Furthermore, its binding affinity to immobilized single EIIIB domain and a large recombinant rat FN fragment comprising FNIII7–15, including EIIIB (FN 7–15 EIIIB), was 1.9 × 10-9 M and 2.25 × 10-9 M, respectively, as determined by biolayer   interferometry (BLI) (Jailkhani et al., 2019; PMID: 31068469). This nanobody was used for IHC of B16F10 and MC38 tumors to detect EIIIB expression (Xie et   al., 2019; PMID: 30936321).

Antibody First   Published

Jailkhani et al. Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14181-14190. doi: 10.1073/pnas.1817442116 PMID:31068469

Note on publication

The original publication presents the   development and application of NJB2, a nanobody that targets   disease-associated extracellular matrix, enabling noninvasive imaging of   tumors, metastases, and fibrosis.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified   antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity   purified

Buffer

PBS with 0.02% Proclin   300.

Concentration

1 mg/ml.

Storage   Recommendation

Store at 4⁰C for up to 3   months. For longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-Fibronectin mAbs

下一篇: Anti-FimA mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号